Trading Members of the Exchange are hereby informed that effective from February 04, 2026, the Equity Shares of Accretion Nutraveda Ltd (Scrip Code: 544694) are listed and admitted to dealings ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Accretion Nutraveda Ltd has been listed on BSE with effect from February 04, 2026, under Scrip Code 544694. The equity shares of the company are now admitted to dealings on the Exchange, meaning investors can buy and sell them from this date. This is a new stock entering the market, making it available for trading by retail and institutional investors. The announcement is a standard regulatory intimation informing trading members about the effective date of listing.
For investors, this means the stock is now tradable on BSE from Feb 4, 2026. Early days of a newly listed stock often see higher volatility as price discovery takes place, so investors should research the company's fundamentals and IPO details carefully before participating.